类器官在肿瘤转化医学中的应用和进展

王若彤; 王欣; 沈波

doi:10.19401/j.cnki.1007-3639.2022.11.009

您当前的位置：

首页 >

文章列表页 >

类器官在肿瘤转化医学中的应用和进展

综述 | 更新时间：2025-12-31

- 类器官在肿瘤转化医学中的应用和进展
- Application and progress of organoids in tumor translational medicine
- 中国癌症杂志 2022年32卷第11期页码：1105-1114
- 作者机构：
  
  南京医科大学附属肿瘤医院，江苏省肿瘤医院肿瘤内科，江苏南京 210009
- 作者简介：
  
  [ "王若彤（ORCID: 0000-0002-0485-6848），硕士在读。" ]
  沈波（ORCID: 0000-0001-5709-5213），博士，主任医师，江苏省肿瘤医院内科行政副主任。
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2022.11.009
  中图分类号： R73
- 收稿：2022-03-15，
  
  修回：2022-05-07，
  
  纸质出版：2022-11-30
- 稿件说明：
移动端阅览
王若彤, 王欣, 沈波. 类器官在肿瘤转化医学中的应用和进展[J]. 中国癌症杂志, 2022,32(11):1105-1114.

Ruotong WANG, Xin WANG, Bo SHEN. Application and progress of organoids in tumor translational medicine[J]. China Oncology, 2022, 32(11): 1105-1114.
王若彤, 王欣, 沈波. 类器官在肿瘤转化医学中的应用和进展[J]. 中国癌症杂志, 2022,32(11):1105-1114. DOI： 10.19401/j.cnki.1007-3639.2022.11.009.

Ruotong WANG, Xin WANG, Bo SHEN. Application and progress of organoids in tumor translational medicine[J]. China Oncology, 2022, 32(11): 1105-1114. DOI： 10.19401/j.cnki.1007-3639.2022.11.009.

摘要

随着精准医学概念的提出，肿瘤作为一类高度异质性的疾病，其个体化治疗已成为精准医学的一个关键领域也受到更多关注。近期提出的类器官模型为肿瘤的基础研究和个体化治疗带来了新突破。类器官指从干细胞或器官祖细胞来源，以类似体内细胞分化的方式组织成的器官特异性的细胞集合。肿瘤类器官指利用原代恶性细胞经过体外3D培养构建的恶性细胞团，在体外培养条件下可持续增殖，一定程度上保留了原代肿瘤的病理学形态特征、基因组与转录组特征、药物敏感性及恶性细胞间异质性，为体外肿瘤研究提供了新方法，尤其在预测患者药物敏感性、药物高通量筛选等方面有巨大潜力，为肿瘤个体化治疗作出了贡献。但该模型仍存在不足，如无法重现体内肿瘤微环境等，使其在临床等方面的应用受限。目前将肿瘤类器官与其他肿瘤成分共培养、与微流控设备和生物打印技术等联合应用将有望弥补其缺陷、突破肿瘤治疗领域的瓶颈。本文将常用肿瘤研究模型的特点进行对比，总结部分肿瘤类器官的培养方法，并描述了肿瘤类器官的临床相关应用，最后对其与其他技术联合应用进行了叙述，并对未来肿瘤类器官的发展方向予以展望。

Abstract

With the introduction of precision medicine

the individualized treatment of cancer has raised increasing interest in the field. Recently

the utilization of organoids as a powerful tool for precision medicine has achieved great breakthroughs for basic research and potential clinical usage. Organoids usually derived from stem/progenitor cells are organ-specific multi-cell clusters organized in a manner like the cell differentiation patterns of their original in vivo counterpart. While keeping the basic pathological/genetic/biological phenotypes of their parental primary cells/tissues

tumor organoids still have a certain potential for proliferative immortalization

which makes organoid-based research/clinical models hopeful tools for precision medicine

especially in predicting drug sensitivity for clinical patients or conducting high-throughput screening of new compounds/drugs for pharmaceutical development. However

obstacles still exist to the clinical application of organoid-based tools

such as the lack of in vivo tumor microenvironment. Currently

with the development of co-culture

microfluidic and bioprinting techniques

breakthroughs have been made for the practical clinical/industrial utilization of organoids. In the current review

we compared the characteristics of common ex vivo tumor models with organoid-based models

summarized the protocols for tumor organoid culturing

reviewed the clinical/industrial application of tumor organoids

and finally look forward to the new outlooks of tumor organoid-based tools in the future.

关键词

Keywords

references

FUJII M , SHIMOKAWA M , DATE S , et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis [J ] . Cell Stem Cell , 2016 , 18 ( 6 ): 827 - 838 . DOI: 10.1016/j.stem.2016.04.003 http://doi.org/10.1016/j.stem.2016.04.003

LESAVAGE B L , SUHAR R A , BROGUIERE N , et al. Next-generation cancer organoids [J ] . Nat Mater , 2022 , 21 ( 2 ): 143 - 159 . DOI: 10.1038/s41563-021-01057-5 http://doi.org/10.1038/s41563-021-01057-5 https://doi.org/10.1038/s41563-021-01057-5 https://doi.org/10.1038/s41563-021-01057-5

LYNCH T J , BELL D W , SORDELLA R , et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J ] . N Engl J Med , 2004 , 350 ( 21 ): 2129 - 2139 . DOI: 10.1056/NEJMoa040938 http://doi.org/10.1056/NEJMoa040938 http://www.nejm.org/doi/abs/10.1056/NEJMoa040938 http://www.nejm.org/doi/abs/10.1056/NEJMoa040938

MAEMONDO M , INOUE A , KOBAYASHI K , et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR [J ] . N Engl J Med , 2010 , 362 ( 25 ): 2380 - 2388 . DOI: 10.1056/NEJMoa0909530 http://doi.org/10.1056/NEJMoa0909530 http://www.nejm.org/doi/abs/10.1056/NEJMoa0909530 http://www.nejm.org/doi/abs/10.1056/NEJMoa0909530

SALMANINEJAD A , VALILOU S F , SHABGAH A G , et al. PD-1/PD-L1 pathway: basic biology and role in cancer immunotherapy [J ] . J Cell Physiol , 2019 , 234 ( 10 ): 16824 - 16837 . DOI: 10.1002/jcp.28358 http://doi.org/10.1002/jcp.28358

VAN MEERBEECK J P , FENNELL D A , DE RUYSSCHER D K . Small-cell lung cancer [J ] . Lancet , 2011 , 378 ( 9804 ): 1741 - 1755 . DOI: 10.1016/S0140-6736(11)60165-7 http://doi.org/10.1016/S0140-6736(11)60165-7

FIEBIG H H , SCHUCHHARDT C , HENSS H , et al. Comparison of tumor response in nude mice and in the patients [J ] . Behring Inst Mitt , 1984 ( 74 ): 343 - 352 .

SATO T , STANGE D E , FERRANTE M , et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium [J ] . Gastroenterology , 2011 , 141 ( 5 ): 1762 - 1772 . DOI: 10.1053/j.gastro.2011.07.050 http://doi.org/10.1053/j.gastro.2011.07.050

KIM S C , PARK J W , SEO H Y , et al. Multifocal organoid capturing of colon cancer reveals pervasive intratumoral heterogenous drug responses [J ] . Adv Sci (Weinh) , 2022 , 9 ( 5 ): e2103360 .

DAI X F , CHENG H Y , BAI Z H , et al. Breast cancer cell line classification and its relevance with breast tumor subtyping [J ] . J Cancer , 2017 , 8 ( 16 ): 3131 - 3141 . DOI: 10.7150/jca.18457 http://doi.org/10.7150/jca.18457

BEN-DAVID U , BEROUKHIM R , GOLUB T R . Genomic evolution of cancer models: perils and opportunities [J ] . Nat Rev Cancer , 2019 , 19 ( 2 ): 97 - 109 . DOI: 10.1038/s41568-018-0095-3 http://doi.org/10.1038/s41568-018-0095-3 https://doi.org/10.1038/s41568-018-0095-3 https://doi.org/10.1038/s41568-018-0095-3

BLEIJS M , VAN DE WETERING M , CLEVERS H , et al. Xenograft and organoid model systems in cancer research [J ] . EMBO J , 2019 , 38 ( 15 ): e101654 .

HOU X Y , DU C , LU L G , et al. Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells [J ] . World J Surg Oncol , 2022 , 20 ( 1 ): 37 . DOI: 10.1186/s12957-022-02510-8 http://doi.org/10.1186/s12957-022-02510-8

WEEBER F , OOFT S N , DIJKSTRA K K , et al. Tumor organoids as a pre-clinical cancer model for drug discovery [J ] . Cell Chem Biol , 2017 , 24 ( 9 ): 1092 - 1100 . DOI: S2451-9456(17)30226-X http://doi.org/S2451-9456(17)30226-X

BEN-DAVID U , HA G , TSENG Y Y , et al. Patient-derived xenografts undergo mouse-specific tumor evolution [J ] . Nat Genet , 2017 , 49 ( 11 ): 1567 - 1575 . DOI: 10.1038/ng.3967 http://doi.org/10.1038/ng.3967

ISHIGURO T , OHATA H , SATO A , et al. Tumor-derived spheroids: relevance to cancer stem cells and clinical applications [J ] . Cancer Sci , 2017 , 108 ( 3 ): 283 - 289 . DOI: 10.1111/cas.13155 http://doi.org/10.1111/cas.13155 https://onlinelibrary.wiley.com/doi/10.1111/cas.13155 https://onlinelibrary.wiley.com/doi/10.1111/cas.13155

WEISWALD L B , BELLET D , DANGLES-MARIE V . Spherical cancer models in tumor biology [J ] . Neoplasia , 2015 , 17 ( 1 ): 1 - 15 . DOI: 10.1016/j.neo.2014.12.004 http://doi.org/10.1016/j.neo.2014.12.004 https://linkinghub.elsevier.com/retrieve/pii/S1476558614001948 https://linkinghub.elsevier.com/retrieve/pii/S1476558614001948

BOUCHERIT N , GORVEL L , OLIVE D . 3D tumor models and their use for the testing of immunotherapies [J ] . Front Immunol , 2020 , 11 : 603640 . DOI: 10.3389/fimmu.2020.603640 http://doi.org/10.3389/fimmu.2020.603640 https://www.frontiersin.org/articles/10.3389/fimmu.2020.603640/full https://www.frontiersin.org/articles/10.3389/fimmu.2020.603640/full

GILAZIEVA Z , PONOMAREV A , RUTLAND C , et al. Promising applications of tumor spheroids and organoids for personalized medicine [J ] . Cancers (Basel) , 2020 , 12 ( 10 ): E2727 .

SATO T , VRIES R G , SNIPPERT H J , et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche [J ] . Nature , 2009 , 459 ( 7244 ): 262 - 265 . DOI: 10.1038/nature07935 http://doi.org/10.1038/nature07935 https://doi.org/10.1038/nature07935 https://doi.org/10.1038/nature07935

ZUMWALDE N A , HAAG J D , SHARMA D , et al. Analysis of i mmune cells from human mammary ductal epithelial organoids reveals Vδ2 + T cells that efficiently target breast carcinoma cells in the presence of bisphosphonate [J ] . Cancer Prev Res (Phila) , 2016 , 9 ( 4 ): 305 - 316 . DOI: 10.1158/1940-6207.CAPR-15-0370-T http://doi.org/10.1158/1940-6207.CAPR-15-0370-T https://aacrjournals.org/cancerpreventionresearch/article/9/4/305/113358/Analysis-of-Immune-Cells-from-Human-Mammary-Ductal https://aacrjournals.org/cancerpreventionresearch/article/9/4/305/113358/Analysis-of-Immune-Cells-from-Human-Mammary-Ductal

BROUTIER L , MASTROGIOVANNI G , VERSTEGEN M M , et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening [J ] . Nat Med , 2017 , 23 ( 12 ): 1424 - 1435 . DOI: 10.1038/nm.4438 http://doi.org/10.1038/nm.4438

SEINO T , KAWASAKI S , SHIMOKAWA M , et al. Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression [J ] . Cell Stem Cell , 2018 , 22 ( 3 ): 454 - 467 .e6. DOI: S1934-5909(17)30510-6 http://doi.org/S1934-5909(17)30510-6

GROSSMAN J E , MUTHUSWAMY L , HUANG L , et al. Organoid sensitivity correlates with therapeutic response in patients with pancreatic cancer [J ] . Clin Cancer Res , 2022 , 28 ( 4 ): 708 - 718 . DOI: 10.1158/1078-0432.CCR-20-4116 http://doi.org/10.1158/1078-0432.CCR-20-4116 https://aacrjournals.org/clincancerres/article/28/4/708/678108/Organoid-Sensitivity-Correlates-with-Therapeutic https://aacrjournals.org/clincancerres/article/28/4/708/678108/Organoid-Sensitivity-Correlates-with-Therapeutic

GANESH K , WU C , O'ROURKE K P , et al. A rectal cancer organoid platform to study individual responses to chemoradiation [J ] . Nat Med , 2019 , 25 ( 10 ): 1607 - 1614 . DOI: 10.1038/s41591-019-0584-2 http://doi.org/10.1038/s41591-019-0584-2

VAN DE WETERING M , FRANCIES H E , FRANCIS J M , et al. Prospective derivation of a living organoid biobank of colorectal cancer patients [J ] . Cell , 2015 , 161 ( 4 ): 933 - 945 . DOI: 10.1016/j.cell.2015.03.053 http://doi.org/10.1016/j.cell.2015.03.053

LI X D , FRANCIES H E , SECRIER M , et al. Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics [J ] . Nat Commun , 2018 , 9 ( 1 ): 2983 . DOI: 10.1038/s41467-018-05190-9 http://doi.org/10.1038/s41467-018-05190-9

CALANDRINI C , SCHUTGENS F , OKA R , et al. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity [J ] . Nat Commun , 2020 , 11 ( 1 ): 1310 . DOI: 10.1038/s41467-020-15155-6 http://doi.org/10.1038/s41467-020-15155-6

GAO D , VELA I , SBONER A , et al. Organoid cultures derived from patients with advanced prostate cancer [J ] . Cell , 2014 , 159 ( 1 ): 176 - 187 . DOI: S0092-8674(14)01047-2 http://doi.org/S0092-8674(14)01047-2

KIM M , MUN H , SUNG C O , et al. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening [J ] . Nat Commun , 2019 , 10 ( 1 ): 3991 . DOI: 10.1038/s41467-019-11867-6 http://doi.org/10.1038/s41467-019-11867-6

YAN H H N , SIU H C , LAW S , et al. A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening [J ] . Cell Stem Cell , 2018 , 23 ( 6 ): 882 - 897 .e11. DOI: S1934-5909(18)30480-6 http://doi.org/S1934-5909(18)30480-6

SEIDLITZ T , MERKER S R , ROTHE A , et al. Human gastric cancer modelling using organoids [J ] . Gut , 2019 , 68 ( 2 ): 207 - 217 . DOI: 10.1136/gutjnl-2017-314549 http://doi.org/10.1136/gutjnl-2017-314549

STEELE N G , CHAKRABARTI J , WANG J , et al. An organoid-based preclinical model of human gastric cancer [J ] . Cell Mol Gastroenterol Hepatol , 2019 , 7 ( 1 ): 161 - 184 . DOI: S2352-345X(18)30130-9 http://doi.org/S2352-345X(18)30130-9

LEE S H , HU W H , MATULAY J T , et al. Tumor evolution and drug response in patient-derived organoid models of bladder cancer [J ] . Cell , 2018 , 173 ( 2 ): 515 - 528 .e17. DOI: S0092-8674(18)30297-6 http://doi.org/S0092-8674(18)30297-6

DROST J , VAN JAARSVELD R H , PONSIOEN B , et al. Sequential cancer mutations in cultured human intestinal stem cells [J ] . Nature , 2015 , 521 ( 7550 ): 43 - 47 . DOI: 10.1038/nature14415 http://doi.org/10.1038/nature14415 https://doi.org/10.1038/nature14415 https://doi.org/10.1038/nature14415

LO Y H , KOLAHI K S , DU Y H , et al. A CRISPR/Cas9-engineered ARID1A-deficient human gastric cancer organoid model reveals essential and nonessential modes of oncogenic transformation [J ] . Cancer Discov , 2021 , 11 ( 6 ): 1562 - 1581 . DOI: 10.1158/2159-8290.CD-20-1109 http://doi.org/10.1158/2159-8290.CD-20-1109 https://aacrjournals.org/cancerdiscovery/article/11/6/1562/666568/A-CRISPR-Cas9-Engineered-ARID1A-Deficient-Human https://aacrjournals.org/cancerdiscovery/article/11/6/1562/666568/A-CRISPR-Cas9-Engineered-ARID1A-Deficient-Human

WERNER R S , KIRSCHNER M B , OPITZ I . Primary lung cancer organoids for personalized medicine-are they ready for clinical use? [J ] . Cancers , 2021 , 13 ( 19 ): 4832 . DOI: 10.3390/cancers13194832 http://doi.org/10.3390/cancers13194832 https://www.mdpi.com/2072-6694/13/19/4832 https://www.mdpi.com/2072-6694/13/19/4832

AISENBREY E A , MURPHY W L . Synthetic alternatives to matrigel [J ] . Nat Rev Mater , 2020 , 5 ( 7 ): 539 - 551 . DOI: 10.1038/s41578-020-0199-8 http://doi.org/10.1038/s41578-020-0199-8

MAHAPATRA C , LEE R D , PAUL M K . Emerging role and promise of nanomaterials in organoid research [J ] . Drug Discov Today , 2022 , 27 ( 3 ): 890 - 899 . DOI: 10.1016/j.drudis.2021.11.007 http://doi.org/10.1016/j.drudis.2021.11.007 https://linkinghub.elsevier.com/retrieve/pii/S1359644621004864 https://linkinghub.elsevier.com/retrieve/pii/S1359644621004864

SHI R , RADULOVICH N , NG C , et al. Organoid cultures as preclinical models of non-small cell lung cancer [J ] . Clin Cancer Res , 2020 , 26 ( 5 ): 1162 - 1174 . DOI: 10.1158/1078-0432.CCR-19-1376 http://doi.org/10.1158/1078-0432.CCR-19-1376

BARTFELD S , BAYRAM T , VAN DE WETERING M , et al. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection [J ] . Gastroenterology , 2015 , 148 ( 1 ): 126 - 136 .e6. DOI: 10.1053/j.gastro.2014.09.042 http://doi.org/10.1053/j.gastro.2014.09.042

TIRIAC H , BELLEAU P , ENGLE D D , et al. Organoid profiling identifies common responders to chemotherapy in pancreatic cancer [J ] . Cancer Discov , 2018 , 8 ( 9 ): 1112 - 1129 . DOI: 10.1158/2159-8290.CD-18-0349 http://doi.org/10.1158/2159-8290.CD-18-0349

CHUA C W , SHIBATA M , LEI M , et al. Single luminal epithelial progenitors can generate prostate organoids in culture [J ] . Nat Cell Biol , 2014 , 16 ( 10 ): 951 - 961 . DOI: 10.1038/ncb3047 http://doi.org/10.1038/ncb3047

WONG C H , SIAH K W , LO A W . Estimation of clinical trial success rates and related parameters [J ] . Biostatistics , 2019 , 20 ( 2 ): 273 - 286 . DOI: 10.1093/biostatistics/kxx069 http://doi.org/10.1093/biostatistics/kxx069

CHEN B Z , DODGE M E , TANG W , et al. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer [J ] . Nat Chem Biol , 2009 , 5 ( 2 ): 100 - 107 . DOI: 10.1038/nchembio.137 http://doi.org/10.1038/nchembio.137

VLACHOGIANNIS G , HEDAYAT S , VATSIOU A , et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers [J ] . Science , 2018 , 359 ( 6378 ): 920 - 926 . DOI: 10.1126/science.aao2774 http://doi.org/10.1126/science.aao2774

MUN S J , RYU J S , LEE M O , et al. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids [J ] . J Hepatol , 2019 , 71 ( 5 ): 970 - 985 . DOI: S0168-8278(19)30402-7 http://doi.org/S0168-8278(19)30402-7

SKARDAL A , ALEMAN J , FORSYTHE S , et al. Drug compound screening in single and integrated multi-organoid body-on-a-chip systems [J ] . Biofabrication , 2020 , 12 ( 2 ): 025017 . DOI: 10.1088/1758-5090/ab6d36 http://doi.org/10.1088/1758-5090/ab6d36 https://iopscience.iop.org/article/10.1088/1758-5090/ab6d36 https://iopscience.iop.org/article/10.1088/1758-5090/ab6d36

CZERNIECKI S M , CRUZ N M , HARDER J L , et al. High-throughput screening enhances kidney organoid differentiation from human pluripotent stem cells and enables automated multidimensional phenotyping [J ] . Cell Stem Cell , 2018 , 22 ( 6 ): 929 - 940 .e4. DOI: S1934-5909(18)30216-9 http://doi.org/S1934-5909(18)30216-9

BROOKS A , LIANG X W , ZHANG Y L , et al. Liver organoid as a 3D in vitro model for drug validation and toxicity assessment [J ] . Pharmacol Res , 2021 , 169 : 105608 . DOI: 10.1016/j.phrs.2021.105608 http://doi.org/10.1016/j.phrs.2021.105608 https://linkinghub.elsevier.com/retrieve/pii/S1043661821001924 https://linkinghub.elsevier.com/retrieve/pii/S1043661821001924

YAO Y , XU X Y , YANG L F , et al. Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer [J ] . Cell Stem Cell , 2020 , 26 ( 1 ): 17 - 26 .e6. DOI: S1934-5909(19)30431-X http://doi.org/S1934-5909(19)30431-X

SCHUMACHER D , ANDRIEUX G , BOEHNKE K , et al. Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures [J ] . PLoS Genet , 2019 , 15 ( 3 ): e1008076 . DOI: 10.1371/journal.pgen.1008076 http://doi.org/10.1371/journal.pgen.1008076 https://dx.plos.org/10.1371/journal.pgen.1008076 https://dx.plos.org/10.1371/journal.pgen.1008076

CORRÒ C , NOVELLASDEMUNT L , LI V S W . A brief history of organoids [J ] . Am J Physiol Cell Physiol , 2020 , 319 ( 1 ): C151 -C165. DOI: 10.1152/ajpcell.00120.2020 http://doi.org/10.1152/ajpcell.00120.2020 https://journals.physiology.org/doi/10.1152/ajpcell.00120.2020 https://journals.physiology.org/doi/10.1152/ajpcell.00120.2020

FIORINI E , VEGHINI L , CORBO V . Modeling cell communication in cancer with organoids: making the complex simple [J ] . Front Cell Dev Biol , 2020 , 8 : 166 . DOI: 10.3389/fcell.2020.00166 http://doi.org/10.3389/fcell.2020.00166

ÖHLUND D , HANDLY-SANTANA A , BIFFI G , et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer [J ] . J Exp Med , 2017 , 214 ( 3 ): 579 - 596 . DOI: 10.1084/jem.20162024 http://doi.org/10.1084/jem.20162024 https://rupress.org/jem/article/214/3/579/42197/Distinct-populations-of-inflammatory-fibroblasts https://rupress.org/jem/article/214/3/579/42197/Distinct-populations-of-inflammatory-fibroblasts

MARUSYK A , TABASSUM D P , JANISZEWSKA M , et al. Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes [J ] . Cancer Res , 2016 , 76 ( 22 ): 6495 - 6506 . DOI: 10.1158/0008-5472.CAN-16-1457 http://doi.org/10.1158/0008-5472.CAN-16-1457

DIJKSTRA K K , CATTANEO C M , WEEBER F , et al. Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids [J ] . Cell , 2018 , 174 ( 6 ): 1586 - 1598 .e12. DOI: S0092-8674(18)30903-6 http://doi.org/S0092-8674(18)30903-6

SAHIN U . Studying tumor-ReacTive T cells: a personalized organoid model [J ] . Cell Stem Cell , 2018 , 23 ( 3 ): 318 - 319 . DOI: S1934-5909(18)30400-4 http://doi.org/S1934-5909(18)30400-4

SACKMANN E K , FULTON A L , BEEBE D J . The present and future role of microfluidics in biomedical research [J ] . Nature , 2014 , 507 ( 7491 ): 181 - 189 . DOI: 10.1038/nature13118 http://doi.org/10.1038/nature13118 https://doi.org/10.1038/nature13118 https://doi.org/10.1038/nature13118

VUNJAK-NOVAKOVIC G , RONALDSON-BOUCHARD K , RADISIC M . Organs-on-a-chip models for biological research [J ] . Cell , 2021 , 184 ( 18 ): 4597 - 4611 . DOI: 10.1016/j.cell.2021.08.005 http://doi.org/10.1016/j.cell.2021.08.005 https://linkinghub.elsevier.com/retrieve/pii/S0092867421009478 https://linkinghub.elsevier.com/retrieve/pii/S0092867421009478

HSU T H , KAO Y L , LIN W L , et al. The migration speed of cancer cells influenced by macrophages and myofibroblasts co-cultured in a microfluidic chip [J ] . Integr Biol (Camb) , 2012 , 4 ( 2 ): 177 - 182 . DOI: 10.1039/C2IB00112H http://doi.org/10.1039/C2IB00112H https://academic.oup.com/ib/article/4/2/177-182/5210385 https://academic.oup.com/ib/article/4/2/177-182/5210385

JIN Y , KIM J , LEE J S , et al. Vascularized liver organoids generated using induced hepatic tissue and dynamic liver-specific microenvironment as a drug testing platform [J ] . Adv Funct Mater , 2018 , 28 ( 37 ): 1801954 . DOI: 10.1002/adfm.201801954 http://doi.org/10.1002/adfm.201801954 https://onlinelibrary.wiley.com/doi/10.1002/adfm.201801954 https://onlinelibrary.wiley.com/doi/10.1002/adfm.201801954

LITTLE M H , COMBES A N . Kidney organoids: accurate models or fortunate accidents [J ] . Genes Dev , 2019 , 33 ( 19/20 ): 1319 - 1345 . DOI: 10.1101/gad.329573.119 http://doi.org/10.1101/gad.329573.119 http://genesdev.cshlp.org/lookup/doi/10.1101/gad.329573.119 http://genesdev.cshlp.org/lookup/doi/10.1101/gad.329573.119

BRASSARD J A , NIKOLAEV M , HÜBSCHER T , et al. Recapitulating macro-scale tissue self-organization through organoid bioprinting [J ] . Nat Mater , 2021 , 20 ( 1 ): 22 - 29 . DOI: 10.1038/s41563-020-00803-5 http://doi.org/10.1038/s41563-020-00803-5

LAWLOR K T , VANSLAMBROUCK J M , HIGGINS J W , et al. Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation [J ] . Nat Mater , 2021 , 20 ( 2 ): 260 - 271 . DOI: 10.1038/s41563-020-00853-9 http://doi.org/10.1038/s41563-020-00853-9

JIANG S W , ZHAO H R , ZHANG W J , et al. An automated organoid platform with inter-organoid homogeneity and inter-patient heterogeneity [J ] . Cell Rep Med , 2020 , 1 ( 9 ): 100161 .

浏览量

3338

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

乳酸调控肿瘤恶性进程的研究进展

组蛋白乳酸化在消化系统肿瘤中的研究进展及展望

类器官在妇科恶性肿瘤药物筛选中的应用

生物3D打印在肿瘤研究及组织工程中的应用

肿瘤类器官研究现状与展望